Search

Displaying results 8251 - 8260 of 10000 in total
  1. Drug

    Vamifeport

    go.drugbank.com/drugs/DB17692
    Investigational

    Vamifeport is being investigated for the treatment of beta-thalassemia.

  2. Drug

    17alpha-methyl-4-hydroxynandrolone

    go.drugbank.com/drugs/DB01540
    ExperimentalIllicit

    17alpha-methyl-4-hydroxynandrolone is a schedule 3 anabolic steroid.

  3. Drug

    Aminomethylbenzoic acid

    go.drugbank.com/drugs/DB13244
    Experimental

    Aminomethylbenzoic acid may be useful as an antifibrinolytic agent [A174994].

  4. Drug

    NSC-663284

    go.drugbank.com/drugs/DB17038
    Experimental

    NSC-663284 is a potent quinolinedione Cdc25 phosphatase inhibitor.[A253052]

  5. Drug

    MANF

    go.drugbank.com/drugs/DB17885
    Experimental

    MANF is a human recombinant mesencephalic, astrocyte-derived neurotrophic factor.

  6. Drug

    ATI-1013

    go.drugbank.com/drugs/DB18185
    Investigational

    ATI-1013 is a fully human nicotine-specific monoclonal antibody.

  7. Drug

    CKD-504

    go.drugbank.com/drugs/DB18235
    Investigational

    CKD-504 is a novel, selective histone deacetylase 6 inhibitor.

  8. Drug

    DR-01

    go.drugbank.com/drugs/DB18258
    Investigational

    DR-01 is a monoclonal antibody directed against human CD94.

  9. Drug

    CALY-002

    go.drugbank.com/drugs/DB18378
    Investigational

    CALY-002 is a humanized monoclonal antibody targeting interleukin-15.

  10. Drug

    VGA039

    go.drugbank.com/drugs/DB18385
    Investigational

    VGA039 is an IgG4 monoclonal antibody directed against protein S.